Hematology and Oncology
Advanced Procedures for Complete Pediatric Cancer Care and Blood Disorders
To see a specialist call (313) 745-KIDS
DMC Children’s Hospital of Michigan treats the most children for inpatient hematology and oncology care in the state of Michigan. The Division of Hematology and Oncology has made major contributions to the understanding and treatment of pediatric blood diseases and cancer.
Services and programs include: bone marrow transplantation, cancer survivorship program, coagulation laboratory, hemophilia and other blood diseases, hematologic disorders, oncology treatment, sickle cell anemia and a thrombosis clinic.
Physicians are involved in extensive clinical, translational and bench research in pediatric blood diseases, coagulation and bleeding disorders and cancer/leukemia. Much of this research is funded by the National Institutes of Health, National Cancer Institute and other agencies.
Members of the division have held many leadership positions with national programs – including the Children’s Oncology Group, Medical Director of the National Hemophilia Foundation and Chair of the International Society of Thrombosis
and Hemostasis Scientific Committee. They have served on editorial boards, publish journal articles and are frequent lecturers at national and international meetings.
Learn more about Leukemia and Lymphoma Research At Children’s Hospital of Michigan
For further information or to schedule an appointment call (313) 745-KIDS or toll-free at (888) 362-2500.
-
Hematology Oncology Services
View our innovative cancer and blood condition services -
Leukemia and Lymphoma
Learn more about leukemia and lymphoma -
Zynteglo Qualified Treatment Center
Children’s Hospital of Michigan is the first and only medical center in Michigan to offer a novel new gene therapy for the rare condition beta thalassemia
Hematology/Oncology Conditions & Treatments
- Anemia
- Aplastic anemia
- Autoimmune anemia
- Autoimmune neutropenia,
- Bleeding Disorders
- Blood Disorders
- Blood clots
- Bone marrow failure disorders
- Diamond-Blackfan anemia
- Fanconi’s anemia
- Glanzmann thrombasthenia
- Hemangiomas
- Hemoglobinopathies
- Hemophilia
- Idiopathic Thrombocytopenic Purpura (ITP)
- Immunohematology
- Neutropenia
- Platelet disorders
- Red blood cell disorders
- Sickle cell anemia
- Thalassemia
- Zynteglo Qualified Treatment Center
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Astrocytoma
- B-cell lymphoma
- Bone tumors
- Brain Tumors
- Burkitt’s leukemia (Mature B-cell leukemia)
- Burkitt’s lymphoma
- Clear cell sarcoma
- Chronic myeloid leukemia (CML)
- CNS germ cell tumors
- Desmoplastic small round cell tumor
- Diffuse intrinsic pontine glioma (DIPG)
- Glioma
- Hepatoblastoma
- Ependymoma
- Ewing’s sarcoma
- Ependymoma
- Germ Cell Tumors
- Hepatoblastoma
- Hodgkin’s Lymphoma
- Infant leukemia
- Juvenile myelomonocytic leukemia (JMML)
- Langerhans histiocytosis (LCH)
- Leukemia
- Lymphoma
- Medulloblastoma
- Melanoma
- Neuroblastoma
- Neurofibromatosis
- Non-Hodgkin’s Lymphoma
- Optic Nerve Gliomas
- Osteogenic Sarcoma
- Osteosarcoma
- Ovarian tumors
- Peripheral nerve sheath tumor
- Primitive Neuroectodermal Tumors (PNET)
- Retinoblastoma
- Rhabdomyosarcoma
- Sarcomas
- Soft tissue sarcomas
- Secondary cancers
- Thalassemia
- T-cell lymphoma
- Testicular tumors
- Thryroid carcinoma
- Wilms Tumor
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Brain tumors
- Chronic myeloid leukemia (CML)
- Ewing’s sarcoma
- Glanzmann thrombasthenia
- Hemoglobinopathies
- Hodgkin lymphoma
- Immunodeficiencies
- Infant leukemia
- Inherited metabolic disorders
- Juvenile myelomonocytic leukemia (JMML)
- Non-Hodgkin lymphoma (NHL)
- Neuroblastoma
- Primitive neuroectodermal tumors (PNET)
- Sickle cell anemia
- Severe combine immunodeficiency (SCID)
- Thalassemia